Abstract
Human β-defensins are cationic peptides produced by epithelial cells that have been proposed to be an important component of immune function at mucosal surfaces. In this study, the expression and inducibility of β-defensins at the ocular surface were investigated in vitro and in vivo. Expression of human β-defensins (hBD) was determined by RT-PCR and immunohistochemistry in tissues of the ocular surface and lacrimal apparatus. Cultured corneal and conjunctival epithelial cells were stimulated with proinflammatory cytokines and supernatants of different ocular pathogens. Real-time PCR and ELISA experiments were performed to study the effect on the inducibility of hBD2 and 3. Expression and inducibility of mouse β-defensins-2, -3 and -4 (mBD2–4) were tested in a mouse ocular surface scratch model with and without treatment of supernatants of a clinical Staphylococcus aureus (SA) isolate by means of immunohistochemistry. Here we show that hBD1, -2, -3 and -4 are constitutively expressed in conjunctival epithelial cells and also partly in cornea. Healthy tissues of the ocular surface, lacrimal apparatus and human tears contain measurable amounts of hBD2 and -3, with highest concentrations in cornea and much lower concentrations in all other tissues, especially tears, suggesting intraepithelial storage of β-defensins. Exposure of cultured human corneal and conjunctival epithelial cells to proinflammatory cytokines and supernatants of various bacteria revealed that IL-1β is a very strong inductor of hBD2 and Staphylococcus aureus increases both hBD2 and hBD3 production in corneal and conjunctival epithelial cells. A murine corneal scratch model demonstrated that β-defensins are only induced if microbial products within the tear film come into contact with a defective epithelium. Our finding suggests that the tear film per se contains so much antimicrobial substances that epithelial induction of β-defensins occurs only as a result of ocular surface damage. These findings widen our knowledge of the distribution, amount and inducibility of β-defensins at the ocular surface and lacrimal apparatus and show how β-defensins are regulated specifically.
Similar content being viewed by others
Abbreviations
- HCE:
-
Human corneal epithelial cells
- HCjE:
-
Human conjunctival epithelial cells
- IL:
-
Interleukin
- TNF:
-
Tumor necrosis factor
- hBD1:
-
Human β-defensin 1
- hBD2:
-
Human β-defensin 2
- hBD3:
-
Human β-defensin 3
- hBD4:
-
Human β-defensin 4
- mBD2:
-
Mouse β-defensin 2
- mBD3:
-
Mouse β-defensin 3
- mBD4:
-
Mouse β-defensin 4
References
Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, Litvinov SV, van Krieken JH, de Boer WI, Hiemstra PS (2002) Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 72:167–174
Aarbiou J, Verhoosel RM, Van Wetering S, De Boer WI, Van Krieken JH, Litvinov SV, Rabe KF, Hiemstra PS (2004) Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 30:193–201
Abedin A, Mohammed I, Hopkinson A, Dua HS (2008) A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Invest Ophthalmol Vis Sci 49:28–33
Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, Tano Y, Handa H (1995) An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci 36:614–621
Bals R, Goldman MJ, Wilson JM (1998a) Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun 66:1225–1232
Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM (1998b) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102:874–880
Batoni G, Maisetta G, Esin S, Campa M (2006) Human beta-defensin-3: a promising antimicrobial peptide. Mini Rev Med Chem 6:1063–1073
Beisswenger C, Bals R (2005) Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci 6:255–264
Bowdish DM, Davidson DJ, Hancock RE (2006) Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 306:27–66
Burd RS, Furrer JL, Sullivan J, Smith AL (2002) Murine beta-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Shock 18:461–464
Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS (2007) A -defensin mutation causes black coat color in domestic dogs. Science 318:1418–1423
Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R (2009) Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 182:1247–1252
Diebold Y, Calonge M, Enriquez de Salamanca A, Callejo S, Corrales RM, Saez V, Siemasko KF, Stern ME (2003) Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci 44:4263–4274
Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI (1985) Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 76:1427–1435
Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U, Adermann K, Klüver E, Vogelmeier C, Becker D, Hedrich R, Forssmann W-G, Bals R (2001) Identification of a novel, multifunctional ß-defensin (human ß-defensin 3) with specific antimicrobial activity. Cell Tissue Res 306:257–264
Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J (2007) Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 179:3958–3965
Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707–5713
Hattenbach LO, Gumbel H, Kippenberger S (1998) Identification of beta-defensins in human conjunctiva. Antimicrob Agents Chemother 42:3332
Haynes RJ, Tighe PJ, Dua HS (1998) Innate defence of the eye by antimicrobial defensin peptides. Lancet 352:451–452
Hinrichsen K, Podschun R, Schubert S, Schroder JM, Harder J, Proksch E (2008) Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother 52:1876–1879
Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM (2006) Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci 47:2369–2380
Huang LC, Jean D, Proske RJ, Reins RY, McDermott AM (2007) Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res 32:595–609
Jones DE, Bevins CL (1992) Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267:23216–23225
Jones DE, Bevins CL (1993) Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 315:187–192
Kawasaki S, Kawamoto S, Yokoi N, Connon C, Minesaki Y, Kinoshita S, Okubo K (2003) Up-regulated gene expression in the conjunctival epithelium of patients with Sjogren’s syndrome. Exp Eye Res 77:17–26
Kumar A, Zhang J, Yu F-SX (2004) innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci 45:3513–3522
Kumar A, Zhang J, Yu FS (2006) Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells. Microbes Infect 8:380–389
Kumar A, Yin J, Zhang J, Yu F-SX (2007) Modulation of corneal epithelial innate immune response to Pseudomonas Infection by flagellin pretreatment. Invest Ophthalmol Vis Sci 48:4664–4670
Lehmann OJ, Hussain IR, Watt PJ (2000) Investigation of beta defensin gene expression in the ocular anterior segment by semiquantitative RT-PCR. Br J Ophthalmol 84:523–526
Li J, Raghunath M, Tan D, Lareu RR, Chen Z, Beuerman RW (2006) Defensins HNP1 and HBD2 stimulation of wound-associated responses in human conjunctival fibroblasts. Invest Ophthalmol Vis Sci 47:3811–3819
Li Q, Kumar A, Gui JF, Yu FS (2008) Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2. Microb Pathog 44:426–434
Li J, Zhu HY, Beuerman RW (2009) Stimulation of specific cytokines in human conjunctival epithelial cells by defensins HNP1, HBD2, and HBD3. Invest Ophthalmol Vis Sci 50:644–653
Liu S, Zhou L, Li J, Suresh A, Verma C, Foo YH, Yap EP, Tan DT, Beuerman RW (2008) Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Chembiochem 9:964–973
McDermott AM (2001) Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr Eye Res 22:64–67
McDermott AM (2004) Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf 2:229–247
McDermott AM (2008) The role of antimicrobial peptides at the ocular surface. Ophthalmic Res 41:60–75
McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ (2003) Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci 44:1859–1865
McIntosh RS, Cade JE, Al-Abed M, Shanmuganathan V, Gupta R, Bhan A, Tighe PJ, Dua HS (2005) The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci 46:1379–1385
McNamara N, Van R, Tuchin OS, Fleiszig SM (1999) Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res 69:483–490
Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW (1993) Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 155:408–413
Narayanan S, Miller WL, McDermott AM (2003) Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci 44:3795–3801
Nguyen TX, Cole AM, Lehrer RI (2003) Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides 24:1647–1654
Niyonsaba F, Ogawa H, Nagaoka I (2004) Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111:273–281
Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127:594–604
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262–3269
Oono T, Shirafuji Y, Huh WK, Akiyama H, Iwatsuki K (2002) Effects of human neutrophil peptide-1 on the expression of interstitial collagenase and type I collagen in human dermal fibroblasts. Arch Dermatol Res 294:185–189
Oren A, Ganz T, Liu L, Meerloo T (2003) In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74:180–182
Paulsen FP, Pufe T, Schaudig U, Held-Feindt J, Lehmann J, Schroder JM, Tillmann BN (2001) Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci 42:2157–2163
Paulsen F, Varoga D, Steven P, Pufe T (2005) Antimicrobial peptides at the ocular surface. In: Zierhut M, Stern ME, Sullivan DA (eds) Immunology of lacrimal gland and tear film. Taylor & Francis, London, pp 97–104
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Qu XD, Lehrer RI (1998) Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun 66:2791–2797
Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC (1998) Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152:1247–1258
Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC (2005) Human defensins. J Mol Med 83:587–595
Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr (2002) Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 99:2129–2133
Semple CA, Gautier P, Taylor K, Dorin JR (2006) The changing of the guard: molecular diversity and rapid evolution of beta-defensins. Mol Divers 10:575–584
Shin JS, Kim CW, Kwon YS, Kim JC (2004) Human beta-defensin 2 is induced by interleukin-1 beta in the corneal epithelial cells. Exp Mol Med 36:204–210
Varoga D, Pufe T, Harder J, Meyer-Hoffert U, Mentlein R, Schroder JM, Petersen WJ, Tillmann BN, Proksch E, Goldring MB, Paulsen FP (2004) Production of endogenous antibiotics in articular cartilage. Arthritis Rheum 50:3526–3534
Varoga D, Pufe T, Mentlein R, Kohrs S, Grohmann S, Tillmann B, Hassenpflug J, Paulsen F (2005) Expression and regulation of antimicrobial peptides in articular joints. Ann Anat 187:499–508
Wilde CG, Griffith JE, Marra MN, Snable JL, Scott RW (1989) Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem 264:11200–11203
Wu M, McClellan SA, Barrett RP, Zhang Y, Hazlett LD (2009) Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J Immunol 183:8054–8060
Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y (2002) Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 169:2516–2523
Yamaguchi Y, Nagase T, Tomita T, Nakamura K, Fukuhara S, Amano T, Yamamoto H, Ide Y, Suzuki M, Teramoto S, Asano T, Kangawa K, Nakagata N, Ouchi Y, Kurihara H (2007) Beta-defensin overexpression induces progressive muscle degeneration in mice. Am J Physiol Cell Physiol 292:C2141–C2149
Yanagi S, Ashitani J, Ishimoto H, Date Y, Mukae H, Chino N, Nakazato M (2005) Isolation of human beta- defensin-4 in lung tissue and its increase in lower respiratory tract infection. Respir Res 6:130
Yang D, Chen Q, Chertov O, Oppenheim JJ (2000) Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 68:9–14
Zaiou M (2007) Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 85:317–329
Zhou L, Huang LQ, Beuerman RW, Grigg ME, Li SF, Chew FT, Ang L, Stern ME, Tan D (2004) Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res 3:410–416
Zhou L, Beuerman RW, Huang L, Barathi A, Foo YH, Li SF, Chew FT, Tan D (2007) Proteomic analysis of rabbit tear fluid: defensin levels after an experimental corneal wound are correlated to wound closure. Proteomics 7:3194–3206
Acknowledgments
We thank Ute Beyer, Stephanie Beilecke, Susann Möschter, Karin Stengel and Regine Worm for excellent technical assistance and Dr. Bernhard Nölle (Department of Ophthalmology, Christian Albrecht University of Kiel) for providing us with clinical samples. Moreover, we are grateful to Deike Varoga (Department of Trauma Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany) for helpful advice and discussion with regard to the corneal scratch model as well as Ute Schulze and Sylvia Dyczek for their help with the translation. This work was supported by the Deutsche Forschungsgemeinschaft (DFG)–program grants PA 738/9-1 and PA 738/9-2, BMBF–Wilhelm Roux Program, Halle, Germany–program grants FKZ 09/16, 14/25, and 16/35, as well as Sicca Forschungsförderung of the professional Association of German Ophthalmologists.
Conflict of interest statement
The authors have no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Garreis, F., Schlorf, T., Worlitzsch, D. et al. Roles of human β-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol 134, 59–73 (2010). https://doi.org/10.1007/s00418-010-0713-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-010-0713-y